These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease. Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485 [TBL] [Abstract][Full Text] [Related]
44. The role of molecular imaging in detecting fibrosis in Crohn's disease. Alyami AS; Madkhali Y; Majrashi NA; Alwadani B; Elbashir M; Ali S; Ageeli W; El-Bahkiry HS; Althobity AA; Refaee T Ann Med; 2024 Dec; 56(1):2313676. PubMed ID: 38346385 [TBL] [Abstract][Full Text] [Related]
45. P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis. Lis-López L; Bauset C; Seco-Cervera M; Macias-Ceja D; Navarro F; Álvarez Á; Esplugues JV; Calatayud S; Barrachina MD; Ortiz-Masià D; Cosín-Roger J Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629116 [TBL] [Abstract][Full Text] [Related]
46. Fibrostenotic Phenotype of Myofibroblasts in Crohn's Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition. de Bruyn JR; van den Brink GR; Steenkamer J; Buskens CJ; Bemelman WA; Meisner S; Muncan V; Te Velde AA; D'Haens GR; Wildenberg ME J Crohns Colitis; 2018 Jun; 12(7):849-859. PubMed ID: 29672662 [TBL] [Abstract][Full Text] [Related]
47. Cross-sectional imaging for assessing intestinal fibrosis in Crohn's disease. Zhong YK; Lu BL; Huang SY; Chen YJ; Li ZP; Rimola J; Li XH J Dig Dis; 2020 Jun; 21(6):342-350. PubMed ID: 32418328 [TBL] [Abstract][Full Text] [Related]
48. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440 [TBL] [Abstract][Full Text] [Related]
49. [Fibrogenesis and inflammatory bowel disease]. Sans M; Masamunt MC Gastroenterol Hepatol; 2007 Jan; 30(1):36-41. PubMed ID: 17266880 [TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of fibrostenosing Crohn's disease. Li J; Mao R; Kurada S; Wang J; Lin S; Chandra J; Rieder F Transl Res; 2019 Jul; 209():39-54. PubMed ID: 30981697 [TBL] [Abstract][Full Text] [Related]
51. Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease. Sazuka S; Katsuno T; Nakagawa T; Saito M; Saito K; Maruoka D; Matsumura T; Arai M; Miyauchi H; Matsubara H; Yokosuka O Dig Dis Sci; 2014 Apr; 59(4):760-8. PubMed ID: 23975339 [TBL] [Abstract][Full Text] [Related]
52. IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells? Bailey JR; Bland PW; Tarlton JF; Peters I; Moorghen M; Sylvester PA; Probert CS; Whiting CV PLoS One; 2012; 7(12):e52332. PubMed ID: 23300643 [TBL] [Abstract][Full Text] [Related]